‹ All stocks
Conexeu Sciences
CNXU · NASDAQ · Healthcare
$3.32
▼ $0.25 (-7.00%)
Day range
$3.32 – $3.60
Year range
$3.15 – $18.79
Open
$3.51
Previous close
$3.57
Market cap
$88.84M
Volume (24h)
$95.8K
Volume (52w)
$317.90K
Performance
7D
▼ -11.94%
1M
▼ -29.06%
3M
▼ -65.02%
6M
▼ -74.60%
1Y
▼ -74.60%
YTD
▼ -74.60%
3Y
▼ -74.60%
5Y
▼ -74.60%
All-time
▼ -74.60%
Key statistics
P/E ratio
-6.78
EPS (TTM)
$-0.49
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
26.8M
About Conexeu Sciences
Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1156.42 | 0.49% |
JNJ Johnson & Johnson |
$254.52 | -0.58% |
ABBV AbbVie |
$262.04 | 0.29% |
MRK Merck & Co. |
$139.70 | -2.76% |
UNH UnitedHealth Group Incorp… |
$371.61 | -0.19% |